Regdanvimab
Product Specifications
CAS Number
2444308-95-4
Target
RAAS, SARS-CoV, Angiotensin-converting Enzyme (ACE)
Related Pathways
Endocrinology/Hormones, Metabolism, Microbiology/Virology
Purity
1
Bioactivity
Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1414045-01 0.02 mg (E-Coli)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details MBS1414045-02 0.1 mg (E-Coli)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details MBS1414045-03 0.02 mg (Yeast)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details MBS1414045-04 0.1 mg (Yeast)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details MBS1414045-05 0.02 mg (Baculovirus)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details MBS1414045-06 1 mg (E-Coli)
Recombinant Shigella boydii serotype 4 UPF0213 protein yhbQ (yhbQ)
Sign In for Pricing
View Details